Reckitt Benckiser Group plc (LON:RKT - Get Free Report)'s share price reached a new 52-week high during trading on Thursday . The company traded as high as GBX 5,386 ($69.34) and last traded at GBX 5,356 ($68.96), with a volume of 15833262 shares traded. The stock had previously closed at GBX 5,186 ($66.77).
Reckitt Benckiser Group Stock Performance
The company has a 50-day moving average price of GBX 5,128.35 and a two-hundred day moving average price of GBX 4,843.88. The company has a market capitalization of £36.60 billion, a PE ratio of 24.55, a PEG ratio of 1.10 and a beta of 0.09. The company has a quick ratio of 0.46, a current ratio of 0.69 and a debt-to-equity ratio of 110.26.
Reckitt Benckiser Group (LON:RKT - Get Free Report) last announced its quarterly earnings results on Thursday, March 6th. The company reported GBX 349.70 ($4.50) EPS for the quarter. Reckitt Benckiser Group had a net margin of 10.78% and a return on equity of 18.70%. Analysts predict that Reckitt Benckiser Group plc will post 331.2110727 EPS for the current fiscal year.
Insider Buying and Selling at Reckitt Benckiser Group
In other news, insider Shannon Eisenhardt sold 1,368 shares of the stock in a transaction dated Tuesday, December 10th. The stock was sold at an average price of GBX 4,723 ($60.81), for a total transaction of £64,610.64 ($83,186.10). 0.05% of the stock is currently owned by company insiders.
About Reckitt Benckiser Group
(
Get Free Report)
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Read More
Before you consider Reckitt Benckiser Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.
While Reckitt Benckiser Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
